Key appointment forms part of ongoing plans to strengthen senior leadership team and support expansion of microfluidic product range for single cell analysis Cambridge, UK: – Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Richard Hammond as Chief Technical Officer. In his […]

CAMBRIDGE, UK – Abcam plc, AIM:ABC and Nasdaq: ABCM (“Abcam” or the “Company“), a global leader in the supply of life science research tools, today provides a further update with respect to the cancellation of admission of its Ordinary Shares to trading on AIM (the “AIM Delisting“), as originally announced on 17 October 2022. As previously […]

HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer and treasurer, effective December 31, 2022. The Company has appointed Jennifer Cote, the Company’s vice president of global finance, as its interim chief financial officer and treasurer, effective upon Mr. Rossi’s resignation. Mr. […]

Michael Chambers, the founding CEO of Aldevron, has been elected to the board of directors for the Whitehead Institute at the Massachusetts Institute of Technology. The Whitehead Institute is a nonprofit biomedical research center in Cambridge, Massachusetts. Chambers is one of two new members elected to a six-year term on the board that were announced […]

SFW Capital-Backed Pion’s Acquisition of Two Square Science Adds Sample Preparation and Remote Monitoring Technology to Augment Its Product Portfolio Billerica, MA:  Pion, Inc. (“Pion”), a leading provider of innovative analytical solutions for drug development, has acquired Two Square Science, a company specializing in sample preparation, content uniformity and remote monitoring solutions for the life […]

Following an agreement in August of this year, CELLINK and the Indian Institute of Science (IISc) have opened the doors to the first 3D bioprinting Centre of Excellence, which will focus on providing researchers tools to advance discoveries in tissue engineering, regenerative medicine and drug discovery. On 9 December 2022, CELLINK, the global leader in developing […]

Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif. — 10x Genomics, Inc.(Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling […]

Company’s Millipore® CTDMO Services (Contract Testing, Development and Manufacturing Organization) to streamline viral vector development and production in Japan Collaboration includes VirusExpress® Platform to accelerate development and clinical research MilliporeSigma to provide hands-on training to Synplogen scientists at M Lab™ Collaboration Center in Japan Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada Life Science business of Merck […]

The Protein Sequencing Company™ Commercializing the Industry’s First System to Enable Next-Generation, Single-Molecule Protein Sequencing Will Serve on HUPO’s Industrial Advisory Board GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it has joined the Human Proteome Organization (HUPO) Industrial Advisory Board (IAB), an international scientific organization focused on fostering […]

Antigen designed to support immunoassay and vaccine development applications Oxford, UK: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the worldís leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein (SEBOV GP). The addition […]